The aim is to explore the clinical values of quantitative detection of serum hepatitis B surface
antigen (HBsAg) and hepatitis B virus e antigen (HBeAg) levels for the virological response …

Background In some previous studies, serum hepatitis B virus RNA (HBV RNA) was
proposed as an HBV viral marker during therapy. However, the dynamic change of HBV …

AIM: To analysis the factors that predict the response to entecavir therapy in chronic hepatitis
patients with hepatitis B virus (HBV) genotype C. METHODS: Fifty patients [hepatitis B e …

Objective To evaluate the efficacy of entecavir treatment up to 96 weeks for patients with
chronic hepatitis B (CHB). Methods The study recruited 62 CHB patients who were admitted …

Abstract Background & Aim The aim was to extract factors from virologic and biochemical
profiles at baseline and 24 weeks of treatment to predict HBeAg seroconversion in patients …

The predictive effect of quantitative anti-hepatitis B core on double-negative HBV DNA and
RNA remains unstudied. We observed dynamic changes in this measure in chronic hepatitis …

Quantification of HBeAg levels has been found to be useful in monitoring and predicting the
outcomes of interferon and lamivudine treatment in HBeAg‐positive patients. The aim of this …

BACKGROUND & AIMS: We aimed to investigate serum hepatitis B surface antigen (HBsAg)
levels in patients with chronic hepatitis B virus (HBV) infection during peginterferon (PEG …

The role of measurement of hepatitis B “s” antigen (HBsAg) during the therapy with oral
nucleos (t) ide analogues is still debatable. The HBsAg declines after 3 years of therapy with …

BACKGROUND: The response rate to antiviral therapy varies greatly among individuals,
and its prediction is still very challenging. OBJECTIVES: To evaluate the usefulness of …